Search
Camrelizumab
go.drugbank.com/drugs/DB14776InvestigationalCamrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
Acrizanib
go.drugbank.com/drugs/DB16081InvestigationalAcrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).
ALM201
go.drugbank.com/drugs/DB17206InvestigationalIt is being investigated in the treatment of various cancers.[A254556]
Zamubafusp alfa
go.drugbank.com/drugs/DB32269Investigational[L55038] It consists of a humanized IgG1 and p5R which is a pan-amyloid reactive peptide.[L55038]
ND7001
go.drugbank.com/drugs/DB05142ExperimentalIt is a new type of antidepressant drug with anxiolytic activity. … It is the first representative of a new generation of psycho-active compounds potentially devoid of several problems seen with existing treatments.
Navitoclax
go.drugbank.com/drugs/DB12340InvestigationalIt is a substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying.
Cirazoline
go.drugbank.com/drugs/DB09202ExperimentalIt is an agonist of α1A, partial agonist of α1B and α1D, and a nonselective antagonist of α2. … It is believed that this combination of properties could make cirazoline an effective vasoconstricting agent.
SB-249553
go.drugbank.com/drugs/DB05285ExperimentalIt is also under by GlaxoSmithKline to treat melanoma and lung cancer.
Befunolol
go.drugbank.com/drugs/DB09013ExperimentalIt is currently in experimental status, and is being tested for the management of open angle glaucoma.